查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1469791

全球药品测试与分析服务市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Pharmaceutical Testing and Analytical Services Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 125 Pages | 商品交期: 最快1-2个工作天内

价格

全球药物测试和分析服务市场需求预计将从 2023 年的 79.8 亿美元达到 2032 年近 149.1 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 7.19%。

药物测试和分析服务涵盖一系列用于评估药物成分和产品的安全性、品质和有效性的实验室技术和方法。这些服务涉及测试药物原材料、中间体和成品，以确保符合监管标准、药典要求和品质规范。药物测试可能包括化学分析、微生物测试、稳定性测试、溶出度测试和生物利用度研究。分析服务提供有关药物配方的特性、纯度、效力和稳定性的关键信息，支持药物开发、製造和监管审批流程。

市场动态

监管机构对药品安全性、有效性和品质的日益重视推动了对综合测试和分析服务的需求。药品测试和分析服务对于确保遵守监管标准、识别杂质以及验证药品的效力、稳定性和纯度至关重要。此外，药物配方（包括生物製剂、生物相似药和特殊药物）日益复杂，推动了对先进分析技术和专业测试服务的需求，以遵守监管要求并确保产品品质。此外，在研发投资激增、慢性病流行以及个人化医疗需求不断增长等因素的推动下，製药和生物技术行业不断扩大，正在推动对合约研究组织 (CRO) 和合约外包测试和分析服务的需求。组织(CMO)。此外，药物测试和分析服务中质谱、色谱、光谱和分子诊断等先进技术的持续采用，提高了分析方法的准确性、灵敏度和通量，从而推动了市场成长。

此外，製药业外包非核心活动、成本控制策略和营运效率的上升趋势正在推动对专业供应商外包测试和分析服务的需求。此外，对产品表征、製程验证和品质控制不断扩大的监管要求推动了对提供合规性、方法开发和验证方面专业知识的专业测试服务的需求。此外，对药品生产设施中生物安全和污染控制的日益关注正在推动对环境监测、微生物测试和无菌测试服务的需求，从而促进市场成长。然而，日益激烈的竞争和监管要求可能会在未来几年挑战药物测试和分析服务市场的发展。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球药物测试和分析服务市场的每个细分市场进行包容性评估。药物测试和分析服务业的成长和趋势为本研究提供了整体方法。

市场区隔

药品测试和分析服务市场报告的这一部分提供了国家和地区层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按服务类型

  • 生物分析测试（基于细胞的测定、病毒学测试等）
  • 方法开发和验证（可萃取物和浸出物方法开发和验证、稳定性指示方法验证、製程杂质方法开发和验证等）
  • 原料测试（重金属测试、完整药典测试等）
  • 稳定性测试（原料药稳定性测试、製剂评估稳定性测试等）
  • 微生物检测（微生物限量检测、无菌检测、内毒素检测等）
  • 其他的

按最终用户

  • 医疗器材公司
  • 製药及生物製药公司
  • 其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲的药物测试和分析服务市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。药物测试和分析服务市场的主要参与者包括 Eurofins Scientific、Laboratory Corporation of America Holdings、Charles River Laboratories International, Inc.、SGS SA、Intertek Group plc、RD Laboratories, Inc.、无锡药明康德有限公司、 Dynalabs LLC （Infinity Laboratories）、ARL Bio Pharma。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：药物测试和分析服务 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按服务类型分類的市场吸引力分析
    • 最终用户的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球药物测试和分析服务市场分析：按服务类型

  • 按服务类型概述
  • 历史和预测数据
  • 按服务类型分析
  • 生物分析测试（细胞分析、病毒学测试等）
  • 方法开发和验证（可萃取物和浸出物方法开发和验证、稳定性指示方法验证、製程杂质方法开发和验证等）
  • 原料测试（重金属测试、完整药典测试等）
  • 稳定性测试（原料药稳定性测试、製剂评估稳定性测试等）
  • 微生物检测（微生物限量检测、无菌检测、内毒素检测等）
  • 其他的

第 6 章：全球药物测试和分析服务市场分析：按最终用户

  • 最终用户概述
  • 历史和预测数据
  • 最终用户分析
  • 医疗器材公司
  • 製药及生物製药公司
  • 其他的

第 7 章：全球药物测试和分析服务市场分析：按地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区国家/地区销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 8 章：药物测试与分析服务公司的竞争格局

  • 药物测试和分析服务市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 9 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Eurofins Scientific
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Laboratory Corporation of America Holdings
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Charles River Laboratories International Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • SGS SA
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Intertek Group plc
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • RD laboratories Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Wuxi AppTec Co. Ltd.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Dynalabs LLC (Infinity Laboratories)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • ARL Bio Pharma
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

Product Code: VMR112114194

The global demand for Pharmaceutical Testing and Analytical Services Market is presumed to reach the market size of nearly USD 14.91 Billion by 2032 from USD 7.98 Billion in 2023 with a CAGR of 7.19% under the study period 2024 - 2032.

Pharmaceutical testing and analytical services encompass a range of laboratory techniques and methods used to assess the safety, quality, and effectiveness of pharmaceutical ingredients & products. These services involve testing pharmaceutical raw materials, intermediates, and finished products to ensure compliance with regulatory standards, pharmacopeial requirements, and quality specifications. Pharmaceutical testing may include chemical analysis, microbiological testing, stability testing, dissolution testing, and bioavailability studies. Analytical services provide critical information on pharmaceutical formulations' identity, purity, potency, and stability, supporting drug development, manufacturing, and regulatory approval processes.

MARKET DYNAMICS

The increasing emphasis by regulatory authorities on drug safety, efficacy, and quality drives the demand for comprehensive testing and analytical services. Pharmaceutical testing and analytical services are crucial in ensuring compliance with regulatory standards, identifying impurities, and validating pharmaceutical products' potency, stability, and purity. Moreover, the growing complexity of drug formulations, including biologics, biosimilars, and specialty drugs, drives the need for advanced analytical techniques and specialized testing services to adhere to regulatory requirements and ensure product quality. Additionally, the expanding pharmaceutical and biotechnology industry, driven by factors such as surging R&D investments, spurring prevalence of chronic diseases, and growing demand for personalized medicine, is fueling the demand for outsourced testing and analytical services from contract research organizations (CROs) and contract manufacturing organizations (CMOs). Furthermore, the spurring adoption of advanced technologies such as mass spectrometry, chromatography, spectroscopy, and molecular diagnostics in pharmaceutical testing and analytical services is enhancing analytical methods' accuracy, sensitivity, and throughput, thereby driving market growth.

Moreover, the rising trend of outsourcing non-core activities, cost containment strategies, and operational efficiencies in the pharmaceutical industry is driving the demand for outsourcing testing and analytical services to specialized providers. Additionally, the expanding regulatory requirements for product characterization, process validation, and quality control drive the demand for specialized testing services that offer expertise in compliance, method development, and validation. Furthermore, the growing focus on biosafety, biosecurity, and contamination control in pharmaceutical manufacturing facilities is driving the demand for environmental monitoring, microbial testing, and sterility testing services, contributing to market growth. However, increasing competition and regulatory requirements may challenge the development of the pharmaceutical testing and analytical services market in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of pharmaceutical testing and analytical services. The growth and trends of pharmaceutical testing and analytical services industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the pharmaceutical testing and analytical services market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Service Type

  • Bioanalytical Testing (Cell-Based Assays, Virology Testing, And Others)
  • Method Development & Validation (Extractables & Leachables Method Development And Validation, Stability-Indicating Method Validation, Process Impurity Method Development & Validation, And Others)
  • Raw Material Testing (Heavy Metal Testing, Complete Compendial Testing, And Others)
  • Stability Testing (Drug Substance Stability Testing, Formulation Evaluation Stability Testing, And Others)
  • Microbial Testing (Microbial Limit Testing, Sterility Testing, Endotoxin Testing, And Others)
  • Others

By End-User

  • Medical Device Companies
  • Pharmaceutical & Biopharmaceutical Companies
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Pharmaceutical Testing and Analytical Services market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Pharmaceutical Testing and Analytical Services market include Eurofins Scientific, Laboratory Corporation of America Holdings, Charles River Laboratories International, Inc., SGS S.A., Intertek Group plc, RD laboratories, Inc., Wuxi AppTec Co., Ltd., Dynalabs LLC (Infinity Laboratories), ARL Bio Pharma. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . PHARMACEUTICAL TESTING AND ANALYTICAL SERVICES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Service Type
    • 3.7.2 Market Attractiveness Analysis By End-user
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL PHARMACEUTICAL TESTING AND ANALYTICAL SERVICES MARKET ANALYSIS BY SERVICE TYPE

  • 5.1 Overview by Service Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Service Type
  • 5.4 Bioanalytical Testing (Cell-based Assays, Virology Testing, and Others) Historic and Forecast Sales by Regions
  • 5.5 Method Development & Validation (Extractables & Leachables Method Development and Validation, Stability-indicating Method Validation, Process Impurity Method Development & Validation, and Others) Historic and Forecast Sales by Regions
  • 5.6 Raw Material Testing (Heavy Metal Testing, Complete Compendial Testing, and Others) Historic and Forecast Sales by Regions
  • 5.7 Stability Testing (Drug Substance Stability Testing, Formulation Evaluation Stability Testing, and Others) Historic and Forecast Sales by Regions
  • 5.8 Microbial Testing (Microbial Limit Testing, Sterility Testing, Endotoxin Testing, and Others) Historic and Forecast Sales by Regions
  • 5.9 Others Historic and Forecast Sales by Regions

6 . GLOBAL PHARMACEUTICAL TESTING AND ANALYTICAL SERVICES MARKET ANALYSIS BY END-USER

  • 6.1 Overview by End-user
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by End-user
  • 6.4 Medical Device Companies Historic and Forecast Sales by Regions
  • 6.5 Pharmaceutical & Biopharmaceutical Companies Historic and Forecast Sales by Regions
  • 6.6 Others Historic and Forecast Sales by Regions

7 . GLOBAL PHARMACEUTICAL TESTING AND ANALYTICAL SERVICES MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2. North America By Segment Sales Analysis
    • 7.3.3. North America By Country Sales Analysis
    • 7.3.4. United State Sales Analysis
    • 7.3.5. Canada Sales Analysis
    • 7.3.6. Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2. Europe by Segment Sales Analysis
    • 7.4.3. Europe by Country Sales Analysis
    • 7.4.4. United Kingdom Sales Analysis
    • 7.4.5. France Sales Analysis
    • 7.4.6. Germany Sales Analysis
    • 7.4.7. Italy Sales Analysis
    • 7.4.8. Russia Sales Analysis
    • 7.4.9. Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2. Asia Pacific by Segment Sales Analysis
    • 7.5.3. Asia Pacific by Country Sales Analysis
    • 7.5.4. China Sales Analysis
    • 7.5.5. India Sales Analysis
    • 7.5.6. Japan Sales Analysis
    • 7.5.7. South Korea Sales Analysis
    • 7.5.8. Australia Sales Analysis
    • 7.5.9. South East Asia Sales Analysis
    • 7.5.10. Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2. Latin America by Segment Sales Analysis
    • 7.6.3. Latin America by Country Sales Analysis
    • 7.6.4. Brazil Sales Analysis
    • 7.6.5. Argentina Sales Analysis
    • 7.6.6. Peru Sales Analysis
    • 7.6.7. Chile Sales Analysis
    • 7.6.8. Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2. Middle East & Africa by Segment Sales Analysis
    • 7.7.3. Middle East & Africa by Country Sales Analysis
    • 7.7.4. Saudi Arabia Sales Analysis
    • 7.7.5. UAE Sales Analysis
    • 7.7.6. Israel Sales Analysis
    • 7.7.7. South Africa Sales Analysis
    • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE PHARMACEUTICAL TESTING AND ANALYTICAL SERVICES COMPANIES

  • 8.1. Pharmaceutical Testing And Analytical Services Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF PHARMACEUTICAL TESTING AND ANALYTICAL SERVICES INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Eurofins Scientific
    • 9.3.1. Company Overview
    • 9.3.2. Company Revenue
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. Laboratory Corporation of America Holdings
    • 9.4.1. Company Overview
    • 9.4.2. Company Revenue
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. Charles River Laboratories International Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Company Revenue
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. SGS S.A.
    • 9.6.1. Company Overview
    • 9.6.2. Company Revenue
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. Intertek Group plc
    • 9.7.1. Company Overview
    • 9.7.2. Company Revenue
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. RD laboratories Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Company Revenue
    • 9.8.3. Products
    • 9.8.4. Recent Developments
  • 9.9. Wuxi AppTec Co. Ltd.
    • 9.9.1. Company Overview
    • 9.9.2. Company Revenue
    • 9.9.3. Products
    • 9.9.4. Recent Developments
  • 9.10. Dynalabs LLC (Infinity Laboratories)
    • 9.10.1. Company Overview
    • 9.10.2. Company Revenue
    • 9.10.3. Products
    • 9.10.4. Recent Developments
  • 9.11. ARL Bio Pharma
    • 9.11.1. Company Overview
    • 9.11.2. Company Revenue
    • 9.11.3. Products
    • 9.11.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Service Type (USD MN)
  • Bioanalytical Testing (Cell-based Assays, Virology Testing, and Others) Market Sales by Geography (USD MN)
  • Method Development & Validation (Extractables & Leachables Method Development and Validation, Stability-indicating Method Validation, Process Impurity Method Development & Validation, and Others) Market Sales by Geography (USD MN)
  • Raw Material Testing (Heavy Metal Testing, Complete Compendial Testing, and Others) Market Sales by Geography (USD MN)
  • Stability Testing (Drug Substance Stability Testing, Formulation Evaluation Stability Testing, and Others) Market Sales by Geography (USD MN)
  • Microbial Testing (Microbial Limit Testing, Sterility Testing, Endotoxin Testing, and Others) Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis Market by End-user (USD MN)
  • Medical Device Companies Market Sales by Geography (USD MN)
  • Pharmaceutical & Biopharmaceutical Companies Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Pharmaceutical Testing And Analytical Services Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Pharmaceutical Testing And Analytical Services Report
  • Market Research Process
  • Market Research Methodology
  • Global Pharmaceutical Testing And Analytical Services Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Service Type
  • Market Attractiveness Analysis by End-user
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Service Type (USD MN)
  • Bioanalytical Testing (Cell-based Assays, Virology Testing, and Others) Market Sales by Geography (USD MN)
  • Method Development & Validation (Extractables & Leachables Method Development and Validation, Stability-indicating Method Validation, Process Impurity Method Development & Validation, and Others) Market Sales by Geography (USD MN)
  • Raw Material Testing (Heavy Metal Testing, Complete Compendial Testing, and Others) Market Sales by Geography (USD MN)
  • Stability Testing (Drug Substance Stability Testing, Formulation Evaluation Stability Testing, and Others) Market Sales by Geography (USD MN)
  • Microbial Testing (Microbial Limit Testing, Sterility Testing, Endotoxin Testing, and Others) Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by End-user (USD MN)
  • Medical Device Companies Market Sales by Geography (USD MN)
  • Pharmaceutical & Biopharmaceutical Companies Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.